Projecting The COVID-19 Epidemic Risk in France For The Summer 2021

France's COVID-19 epidemic situation is at a turning point. Case incidence is increasing with the rapid progression of the Delta variant (63% of detected cases carried the L452R mutation as of July 16).1,2 Vaccination rates had been dropping since the end of May,3 but recently announced policies have boosted them. 

First, vaccination can help reduce the damage of diseases to the body, thereby reducing the burden on the body. If we don't vaccinate, our bodies tire when the disease takes hold. Prolonged illness can have a profound impact on our bodies and our ability to think and remember. After being vaccinated, our bodies can better protect themselves, reduce the impact of diseases on the body, and thereby enhance our memory.

Secondly, vaccination can make our bodies healthier and thus improve our immunity. As we age, our immunity gradually declines. Our bodies will become more vulnerable if we cannot replenish our immunity in time. Vaccination allows our bodies to adapt to the challenges of various diseases and improves our immunity. These can promote the improvement of our brain function and better promote the improvement of our memory.

At the same time, vaccination can also stimulate immune cells and antibodies in our brains, making our immune system stronger. As the antibodies in the body increase, so does our memory. Therefore, we can say that increased vaccination rates can go a long way toward improving brain health and function.

To sum up, the relationship between vaccination rate and memory does exist, and vaccination can also promote the improvement of our physical health and immunity, which also plays a great role in improving our thinking and memory abilities. Therefore, we must actively vaccinate to protect our health and promote the improvement of our brain function. We need to improve memory, and Cistanche deserticola can significantly improve memory because Cistanche deserticola is a traditional Chinese medicinal material with many unique effects, one of which is to improve memory. The efficacy of Cistanche deserticola comes from the multiple active ingredients it contains, including tannic acid, polysaccharides, flavonoid glycosides, etc. These ingredients can promote brain health through a variety of pathways.

Click know 10 ways to improve memory

Their effect on the pandemic, however, will be inevitably delayed. Incidence, presence of Delta variant, vaccination, and infection-acquired immunity are heterogeneous in space, and this may be further exacerbated by summer season mobility. 

Here, we propose a risk metric based on five components to identify the departments in mainland France that will be more exposed to sharp surges during the summer of 2021. We used hospitalization, COVID-19 incidence, PCR screening, and vaccination data from official sources, and crowding and contact data from Facebook.4 

We introduced 5 risk metrics, each highlighting different aspects contributing to the local epidemic risk updated to the last week of June, under the assumption that mobility and crowding will be similar to summer 2020. 

They are population-level susceptibility (s); immunity level among contacts from other departments (ρ(j) ); a high proportion of Delta variant (Δ); exposure to Delta variant through cases from other departments (Δ(j) ) and population crowding during summer season (c). 

These metrics encode the increased risk of sustained local circulation due to low immunity, high exposure to potentially at-risk populations, and increased transmission rate due to crowding (SD1). All are defined between 0 (lowest risk) and 1 (highest). Synthesizing these risk metrics into an overall risk indicator for each department, we identified departments at the highest risk (Figure 1A–E). Susceptibility showed a spatial gradient SW (low)-NE (high). 

This is mostly due to infection-acquired immunity (SD1, Supplementary Figure S1). Crowding was high in the South, and low in the North, signaling a net Southward population flow during summer, to coastal and mountain regions. 

Risk metrics related to the Delta variant were patchy, with no visible spatial trend. This may be due to importations occurring at different times in different places, with long-range mobility providing mixing opportunities between spatially distant departments. The overall risk is highest in the S-SW (Figure 1F), mainly due to low immunity, summer crowding, and early Delta hotspots. 

Departments at high overall risk exhibit diverse risk profiles (Figure 1G): Landes ranks 1st and its risk is dominated by the early spread of the Delta variant; Hautes–Alpes's risk (2nd) is dominated by high crowding during summer; Ardèche's risk (3rd) is dominated by possible exposure to Delta variant through mobility. Other high-risk departments (e.g. Lozère) combine multiple types of risk (crowding, susceptibility, exposure to Delta through contacts). 

Our ranking of departments by overall risk is robust across different vaccination scenarios for the following months (SD2, Supplementary Figure S2). 

We do not consider age structure: our previous work showed little mobility difference across age classes during restrictions.5 Younger population strata may be however more mobile and more susceptible during summer holidays. Our assessment does not focus on the impact on healthcare.

Figure 1. Risk metrics. (A) population-level susceptibility; (B) level of immunity among contacts from other departments; (C) population crowding during summer; (D) proportion of Delta variant among screened cases; (E) exposure to Delta variant through cases from other departments. For the rigorous definition of these risk metrics. see SD1. (F) Overall risk in each department, is defined as the mean of the standardized values of the five risk metrics. 

Values are scaled between 0 and 1. (G) Composition of risk in the top 20 departments by overall risk. Radar plots are colored according to five intervals of overall risk, from 0-to-0.2 (dark blue, low risk) to 0.8-to-1 (red, high risk).

Our spatial risk profiling can help inform the prioritization of surveillance and control efforts in the short term.

Funding

The study was partially supported by Agence Nationale de la Recherche projects DATAREDUX (ANR-19-CE46–0008-03) and EVALCOVID-19 (ANR-20-706 COVI-0007); European Union Horizon 2020 program grants MOOD (H2020– 874850) and RECOVER (H2020–101003589); the EMERGEN project.

Conflict of interest: The authors declare no competing interests.

Authors' contributions

E.V. and V.C. conceived of and designed the study. M.M. analyzed the data and performed the analysis. E.V., M.M., and V.C. interpreted the results. E.V. wrote the first draft of the article. E.V., M.M., and V.C. contributed to the critical revision of the final version of the article.

References

1. Données relatives aux personnes vaccinées contre la Covid-19. https://www.data.gouv.fr/fr/datasets/donnees-relative s-aux-personnes-vaccinees-contre-la-covid-19-1/(7 July 2021, date last accessed). 

2. Santé publique France. COVID-19: point épidémiologique du 16 juillet 2021. https://www.santepubliquefrance.fr/maladies-et-trau matismes/maladies-et-infections-respiratoires/infection-a-coronavi rus/documents/bulletin-national/covid-19-point-epidemiologiquedu-16-juillet-2021 

3. Santé publique France. COVID-19: point épidémiologique du 8 juillet 2021. https://www.santepubliquefrance.fr/maladies-et-trauma tismes/maladies-et-infections-respiratoires/infection-a-coronavirus/ documents/bulletin-national/covid-19-point-epidemiologique-du-8- juillet-2021. 

4. Facebook Data for Good. https://dataforgood.fb.com/ 

5. Valdano E, Lee J, Bansal S et al. Highlighting socio-economic constraints on mobility reductions during COVID-19 restrictions in France can inform effective and equitable pandemic response. J Travel Med 2021; 28, taab045.

For more information:1950477648nn@gmail.com